Abstract:Background Although statistical models for predicting type 1 diabetes risk have been developed, approaches that reveal clinically meaningful clusters in the at-risk population and allow for non-linear relationships between predictors are lacking. We aimed to identify and characterize clusters of islet autoantibody-positive individuals that share similar characteristics and type 1 diabetes risk. Methods We tested a novel outcome-guided clustering method in initially non-diabetic autoantibody-positive relatives of individuals with type 1 diabetes, using the TrialNet Pathway to Prevention (PTP) study data (n=1127). The outcome of the analysis was time to type 1 diabetes and variables in the model included demographics, genetics, metabolic factors and islet autoantibodies. An independent dataset (Diabetes Prevention Trial of Type 1 Diabetes, DPT-1 study) (n=704) was used for validation. Findings The analysis revealed 8 clusters with varying type 1 diabetes risks, categorized into three groups. Group A had three clusters with high glucose levels and high risk. Group B included four clusters with elevated autoantibody titers. Group C had three lower-risk clusters with lower autoantibody titers and glucose levels. Within the groups, the clusters exhibit variations in characteristics such as glucose levels, C-peptide levels, age, and genetic risk. A decision rule for assigning individuals to clusters was developed. The validation dataset confirms that the clusters can identify individuals with similar characteristics. Interpretation Demographic, metabolic, immunological, and genetic markers can be used to identify clusters of distinctive characteristics and different risks of progression to type 1 diabetes among autoantibody-positive individuals with a family history of type 1 diabetes. The results also revealed the heterogeneity in the population and complex interactions between variables. Funding National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121843), the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (cooperative agreements U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085461, U01 DK085465, U01 DK085466, U01 DK085476, U01 DK085499, U01 DK085509, U01 DK103180, U01 DK103153, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK106994, U01 DK107013, U01 DK107014, UC4 DK106993, UC4DK117009), and the Juvenile Diabetes Research Foundation.

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score

Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young.

A multi-ancestry genome-wide association study in type 1 diabetes

Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis

Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes

Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

Feature Ranking of Type 1 Diabetes Susceptibility Genes Improves Prediction of Type 1 Diabetes

A comparison of type 2 diabetes risk allele load between African Americans and European Americans

Polygenic Risk for Type 2 Diabetes in African Americans

1463-P: Genetic Heterogeneity and Clinical Subtypes of Type 1 Diabetes

Identification of Novel T1D Risk Loci and Their Association with Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study

Genetic association and machine learning improves discovery and prediction of type 1 diabetes

Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes

Type 1 Diabetes Risk Phenotypes Using Cluster Analysis

A Strategy for Combining Minor Genetic Susceptibility Genes to Improve Prediction of Disease in Type 1 Diabetes

Transferability and Fine Mapping of Type 2 Diabetes Loci in African Americans

Multi-ancestry polygenic mechanisms of type 2 diabetes

Genetics of Type 2 Diabetes: Implications from Large-Scale Studies

Genetic Factors and Risk of Type 2 Diabetes among Women with a History of Gestational Diabetes: Findings from Two Independent Populations

Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population

Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes